Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AroCell

AroCell?uq=kzBhZRuG
2003 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
AROC STOCK SYMBOL
$0.55 SHARE PRICE (As of Wednesday Closing)
Description

Developer of biomarker blood tests to support the prognosis and follow up of cancer patients. The company develops and commercializes tests that can be used in the prognosis, monitoring and follow-up of cancer. It has developed a test, the TK 210 ELISA for measuring the enzyme TK1, which is a protein that is elevated in the blood when there is increased cell turnover (cell growth and cell death) within the patient.

Website
Formerly Known As
Xi Bao Research
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
STO
Primary Office
  • Uppsala Business Park
  • Virdings allé 32 B
  • 754 50 Uppsala
  • Sweden

+46 070-692 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AroCell’s full profile, request a free trial.

AroCell Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.38 - $0.90 $21.9M $0.53 -$0.07 126K 39.4M

AroCell Financials Summary

In Thousands,
USD
TTM
31-Mar-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 8,415 9,842 16,581 34,789
Revenue 53 59 6
EBITDA (2,065) (2,021) (1,076) (886)
Net Income (2,065) (2,021) (1,078) (886)
Total Assets 5,513 6,048 7,293 8,835
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AroCell Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore AroCell‘s full profile, request access.

Request full access to PitchBook

AroCell Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore AroCell‘s full profile, request access.

Request full access to PitchBook

AroCell Executive Team (9)

Name Title Board
Seat
Contact
Info
Jan Stålemark Chief Executive Officer
Ann Hammarstrand Chief Financial Officer
Staffan Eriksson Ph.D Co-Founder, Chief Scientific Officer & Board Member
Arne Ferstad Co-Founder
Bernhard Tribukait Co-Founder

1 Former Executive

You’re viewing 5 of 9 executives. Get the full list »

AroCell Board Members (2)

Name Representing Role Since Contact
Info
Erik Walldén Self Chairman 000 0000
Staffan Eriksson Ph.D AroCell Co-Founder, Chief Scientific Officer & Board Member 000 0000